[1]Hachinski V C, Potter P, Merskey H. Leuko-araiosis[J]. Arch Neurol, 1987, 44(1): 21-23.
[2]Grueter B E, Schulz U G. Age-related cerebral white matter disease (leukoaraiosis): a review[J]. Postgrad Med J, 2012, 88(1036): 79-87.
[3]de Havenon A, Meyer C, McNally J S, et al. Subclinical cerebrovascular disease: epidemiology and treatment[J]. Curr Atheroscler Rep, 2019, 21(10): 39.
[4]Shen Z, Xiang M, Chen C, et al. Glutamate excitotoxicity: potential therapeutic target for ischemic stroke[J]. Biomed Pharmacother, 2022, 151: 113125.
[5]Guo M N, Hao X Y, Tian J, et al. Human blood metabolites and lacunar stroke: a Mendelian randomization study[J]. Int J Stroke, 2023, 18(1): 109-116.
[6]Sun C C, Gao M M, Wang F F, et al. Serum metabolomic profiling in patients with Alzheimer disease and amnestic mild cognitive impairment by GC/MS[J]. Biomed Chromatogr, 2020, 34(9): e4875.
[7]Yang Z, Wang J, Chen J, et al. High-resolution NMR metabolomics of patients with subjective cognitive decline plus: perturbations in the metabolism of glucose and branched-chain amino acids[J]. Neurobiol Dis, 2022, 171: 105782.
[8]Fan X Y, Zhang L X, Li H J, et al. Role of homocysteine in the development and progression of Parkinsons disease[J]. Ann Clin Transl Neurol, 2020, 7(11): 2332-2338.
[9]Iovino L, Tremblay M E, Civiero L. Glutamate-induced excitotoxicity in Parkinson's disease: the role of glial cells[J]. J Pharmacol Sci, 2020, 144(3): 151-164.
[10]王秀莉, 韩锟. 脑小血管病患者血液氨基酸谱和脂肪酸谱变化[J]. 卒中与神经疾病, 2020, 27(5): 609-613.
[11]Fazekas F, Kleinert R, Offenbacher H, et al. Pathologic correlates of incidental MRI white matter signal hyperintensities[J]. Neurology, 1993, 43(9): 1683-1689.
[12]Mahbub M H, Yamaguchi N, Hase R, et al. Plasma branched-chain and aromatic amino acids in relation to hypertension[J]. Nutrients, 2020, 12(12): 3791.
[13]Vanweert F, Schrauwen P, Phielix E. Role of branched-chain amino acid metabolism in the pathogenesis of obesity and type 2 diabetes-related metabolic disturbances BCAA metabolism in type 2 diabetes[J]. Nutr Diabetes, 2022, 12(1): 35.
[14]Zhao E, Giamberardino S N, Pagidipati N J, et al. Branched-chain amino acids in computed tomography-defined adipose depots and coronary artery disease: a promise trial biomarker substudy[J]. J Am Heart Assoc, 2023, 12(11): e028410.
[15]Xu H, Wang X, Geng G, et al. Association of circulating branched-chain amino acids with cardiovascular diseases: a Mendelian randomization study[J]. Nutrients, 2023, 15(7): 1580.
[16]Xu Y Y, Jiang H J, Li L, et al. Branched-chain amino acid catabolism promotes thrombosis risk by enhancing tropomodulin-3 propionylation in platelets[J]. Circulation, 2020, 142(1): 49-64.
[17]Zhenyukh O, González-Amor M, Rodrigues-Diez R R, et al. Branched-chain amino acids promote endothelial dysfunction through increased reactive oxygen species generation and inflammation[J]. J Cell Mol Med, 2018, 22(10): 4948-4962.
[18]Bifari F, Dolci S, Bottani E, et al. Complete neural stem cell (NSC) neuronal differentiation requires a branched chain amino acids-induced persistent metabolic shift towards energy metabolism[J]. Pharmacol Res, 2020, 158: 104863.
[19]Qi B, Zhang Y Y, Xu B, et al. Metabolomic characterization of acute ischemic stroke facilitates metabolomic biomarker discovery[J]. Appl Biochem Biotechnol, 2022, 194(11): 5443-5455.
[20]Ormstad H, Verkerk R, Sandvik L. Serum phenylalanine, tyrosine, and their ratio in acute ischemic stroke: on the trail of a biomarker?[J]. J Mol Neurosci, 2016, 58(1): 102-108.
[21]Wang M L, Zhang X X, Yu M M, et al. Prevalence of white matter hyperintensity in young clinical patients[J]. AJR Am J Roentgenol, 2019, 213(3): 667-671.
[22]Yu X Y, Wang G H, Zhan J, et al. Risk factors of pure leukoaraiosis and the association with preclinical carotid atherosclerosis[J]. Atherosclerosis, 2018, 275: 328-332.
[23]Al-Hashel J Y, Alroughani R, Gad K, et al. Risk factors of white matter hyperintensities in migraine patients[J]. BMC Neurol, 2022, 22(1): 159.
[24]中国研究型医院学会脑小血管病专业委员会《中国脑小血管病诊治专家共识》编写组. 中国脑小血管病诊治专家共识2021[J]. 中国卒中杂志, 2021, 16(7): 716-726.
[25]Sudre C H, Smith L, Atkinson D, et al. Cardiovascular risk factors and white matter hyperintensities: difference in susceptibility in South Asians compared with Europeans[J]. J Am Heart Assoc, 2018, 7(21): e010533.
|